MAXCYTE, INC. Annual Return On Equity in % from 2020 to 2023

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Maxcyte, Inc. quarterly/annual Return On Equity history and growth rate from 2020 to 2023.
  • Maxcyte, Inc. Return On Equity for the quarter ending September 30, 2024 was -16 %, a 4.3% decline year-over-year.
  • Maxcyte, Inc. annual Return On Equity for 2023 was -15.9 %, a 73.3% decline from 2022.
  • Maxcyte, Inc. annual Return On Equity for 2022 was -9.17 %, a 17.5% increase from 2021.
  • Maxcyte, Inc. annual Return On Equity for 2021 was -11.1 %, a 72.6% increase from 2020.
Return On Equity, Annual (%)
Return On Equity, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2023 -15.9 -6.72 -73.3% Jan 1, 2023 Dec 31, 2023
2022 -9.17 +1.94 +17.5% Jan 1, 2022 Dec 31, 2022
2021 -11.1 +29.5 +72.6% Jan 1, 2021 Dec 31, 2021
2020 -40.6 Jan 1, 2020 Dec 31, 2020
* An asterisk sign (*) next to the value indicates that the value is likely invalid.